Flamaryx 7,5 mg, 15 mg TABLET
PDF Leaflet Revision Date: 13 August 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute sciatica.
Dosage (summary)
Adults: 7.5 mg to 15 mg once daily depending on condition.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation; may impair fertility.
Key Drug Interactions
- Lithium
- Methotrexate
- Anticoagulants
- ACE inhibitors
Contraindications
- Hypersensitivity
- Active peptic ulcer disease
- Severe renal impairment
- Pregnancy
- Lactation
Common side effects
- Gastrointestinal bleeding
- Dyspepsia
- Headache
- Dizziness
Counselling Points
- Take with food and water
- Report unusual abdominal symptoms
- Monitor for signs of hypersensitivity
Serious warnings
- Cardiovascular events
- Gastrointestinal perforation
- Serious skin reactions
Important Disclaimer
The Flamaryx 7,5 mg, 15 mg TABLET professional information leaflet below is the property of Aurogen South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
